Related Experiment Video
Updated: Apr 1, 2026

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
The role of interatrial stenting in the management of CHD
Mehmet Balci1, Sezen Ugan Atik1, Selman Gokalp1
1Pediatric Cardiology, Ministry of Health Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training Hospital, Türkiye.
Insights
Interatrial stenting is a safe and effective treatment for pediatric congenital heart disease (CHD), improving hemodynamics. This study evaluated its success and outcomes in young patients.
Area of Science:
- Pediatric Cardiology
- Interventional Cardiology
- Congenital Heart Disease
Background:
- Interatrial stenting is crucial for optimizing hemodynamics in pediatric congenital heart disease (CHD).
- It establishes sustained interatrial communication.
- This intervention is vital for managing complex cardiac conditions in children.
Purpose of the Study:
- To evaluate the procedural success of interatrial stenting in pediatric patients.
- To assess clinical outcomes and mortality rates post-intervention.
- To identify factors influencing hemodynamic improvement after stenting.
Main Methods:
- A retrospective analysis of 16 pediatric patients undergoing interatrial stenting (2018-2024).
- Patients were grouped by age: ≤12 months (Group 1) and >12 months (Group 2).
- Demographic, procedural, and follow-up data were analyzed.
Main Results:
- Procedural success was high (93.8%), with one acute failure.
- Common diagnoses included borderline left ventricle and hypoplastic left heart syndrome.
- Median follow-up was 17.5 months; 37.5% mortality, no stent thrombosis.
Conclusions:
- Interatrial stenting is a safe and effective palliative option for pediatric CHD.
- It significantly improves hemodynamics.
- The procedure serves as a bridge to definitive surgical treatment.
Background:
Interatrial stenting has become an essential intervention for children with CHD requiring sustained interatrial communication to optimise systemic and pulmonary haemodynamics. This study aimed to evaluate procedural success, clinical outcomes, and factors influencing haemodynamic improvement in a single-centre paediatric cohort.
Methods:
A retrospective study was conducted on 16 patients who underwent interatrial stenting between 2018 and 2024. Patients were categorised by age as Group 1 (≤12 months, n = 10) and Group 2 (>12 months, n = 6). Demographic, procedural parameters, and follow-up data were analysed.
Results:
Sixteen patients (median age 10.5 months, median weight 5.0 kg) underwent interatrial stenting. The most frequent diagnosis was borderline left ventricle (37.5%), followed by hypoplastic left heart syndrome (25%) and myocarditis (12.5%). Procedural success was achieved in 15 of 16 patients (93.8%), with one acute failure due to stent embolisation. The median radiation exposure was 244.5 mGy (interquartile range 123.8-447.0). Radiation exposure correlated positively with patient weight (rs = 0.596, p = 0.015). During a median follow-up of 17.5 months, six patients (37.5%) died, and two required redilation. No stent thrombosis occurred.
Conclusion:
Interatrial stenting is a safe and effective palliative intervention for paediatric CHD, providing significant haemodynamic improvement and bridging to definitive surgical management.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Rheumatic Heart Disease III: Medical Management
Mitral Stenosis I: Introduction
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis IV: Nursing Management

